Alpha-1 Antitrypsin Deficiency Genetic Testing

Carrier Test for Autosomal Recessive Conditions

Carrier Test for Autosomal Recessive Conditions, Opens dialog

Overview

Alpha-1 antitrypsin (AAT) is a proteinprotein normally found in the lungs and the bloodstream. It helps protect the lungs from diseases such as emphysemaemphysema and chronic obstructive pulmonary disease (COPD)chronic obstructive pulmonary disease (COPD). Some people do not make enough of this protein or they make an abnormal type of AAT, either of which can cause AAT deficiency. These people are more likely to have lung diseases and will get them at a younger-than-normal age (30 to 40 years old). Some types of abnormal AAT can also damage the liver. AAT deficiency is a rare disorder and is the only known genetic (inherited) factor that increases your chances for developing emphysema.

Alpha-1 antitrypsin deficiency is caused by a change, or mutation, in the genegene that tells the body how to make alpha-1 antitrypsin. There are many kinds of possible changes in this gene, but only a few cause problems. To have this condition, you have to get the changed gene from both parents.

If you receive only one changed gene, you do not have the disease but are a carriercarrier. The good copy of the gene you received from your other parent is enough to tell your body how to properly make alpha-1 antitrypsin. Some people who carry the changed gene may have very mild symptoms of the deficiency.

Treatment for alpha-1 antitrypsin deficiency involves avoiding substances—especially cigarette smoke—that could harm your lungs. Also try to avoid dust and workplace chemicals. You also may want to avoid alcohol because of the risk of liver damage. Exercise can improve your stamina and overall health. You may also need medicines and other treatments to help you breathe easier and stay as healthy and strong as you can.

The only treatment available for the lack of the protein is plasmaplasma containing alpha-1 antitrypsin. This is usually given only to people who have very low levels of AAT in their blood. It is not clear that this treatment is any better than avoiding smoke and other lung-damaging chemicals. The plasma is made from the blood of many donors and is treated to reduce the chance of spreading an infectious disease. You receive the plasma through an I.V.I.V., usually every 3 to 4 weeks for life.

About the Test

A blood test can measure the amount of alpha-1 antitrypsin (AAT) in your blood. You may have AAT deficiency if your levels are low or if the blood test is not able to find any AAT in your blood. If your AAT level is lower than normal, the blood sample can be tested to look for abnormal types of alpha-1 antitrypsin. People who carry the changed gene may be more at risk for symptoms if they have certain types of alpha-1 antitrypsin.

Normal alpha-1 antitrypsin levels are 100–200 mg/dLmg/dL or 1.0–2.0 g/Lg/L.^{footnote 1footnote 1}

Although this blood test is highly reliable, no test is 100% accurate. This test cannot predict when—or whether—you will develop symptoms or how severe they will be.

Deciding About Testing

The decision to have the test is personal. You may have emotional, financial, and family reasons for taking or not taking the test.

You may choose to have the test because:

You have unexplained lung problems and want to know whether you have this condition.
You have been diagnosed with emphysema or COPD and want to find out if you have AAT deficiency.
Other people in your family have AAT deficiency.
Other people in your family have unexplained lung disease or liver disease.
You want to take steps to protect your health if you find out you have the condition.
You would be relieved to know that you do not have the changed gene.
You would change your decision about having children because of test results.
Your insurance would pay for the test.

You may decide not to be tested because:

You do not have symptoms of lung disease.
No one in your family has AAT deficiency or lung or liver disease.
You would be worried if you knew that you might get lung or liver disease some day.
You do not smoke and you already are taking good care of yourself. You think there is nothing more you could do to prevent or delay the disease.
The test cannot predict whether you will ever have symptoms of this condition.
You do not have insurance or your insurance would not pay for the test.
You are worried that the test results might cause problems for you at work or make it hard for you to get health insurance. It's important to know that a law in the United States, called the Genetic Information Nondiscrimination Act of 2008 (GINA), protects people who have genetic differences that may affect their health. GINA prevents employers and health insurance companies from using genetic information about people to affect decisions. This law does not cover life insurance, disability insurance, or long-term care insurance. And it doesn't protect people who work for companies with fewer than 15 employees.

Learn more

COPD and Alpha-1 Antitrypsin (AAT) DeficiencyCOPD and Alpha-1 Antitrypsin (AAT) Deficiency

Information about Alpha-1 Antitrypsin Deficiency Genetic Testing

Genetic Counseling

The results of genetic testing can affect your life. It may be a good idea to get genetic counselinggenetic counseling before deciding to have testing. Genetic counselors can explain the pros and cons of testing, but you make the decision about whether to have the test. A genetic counselor can help you make well-informed decisions. Genetic counseling can help you and your family:

Understand medical facts about a disease and what you may be able to do to manage it.
Understand how your family history contributes to the development of a disease.
Explain the results of a genetic test.
Help you find resources, including getting referrals to specialists or finding local support groups.

Genetic counselors have specialized training in medical genetics and counseling. They are sensitive to the physical and emotional aspects of these decisions. Your privacy and confidentiality are carefully protected.

Learn more

Genetic Testing and ScreeningGenetic Testing and Screening

References

Citations

Fischbach FT, Dunning MB III, eds. (2009). Manual of Laboratory and Diagnostic Tests, 8th ed. Philadelphia: Lippincott Williams and Wilkins.

Current as of: November 15, 2023

Author: Ignite Healthwise, LLC StaffIgnite Healthwise, LLC Staff

Clinical Review BoardClinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Ignite Healthwise, LLC, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of UseTerms of Use. Learn how we develop our contenthow we develop our content.

To learn more about Ignite Healthwise, LLC, visit webmdignite.comwebmdignite.com.

Page Footer

I want to...

Audiences

Secure Member Sites

The Cigna Group Information

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details Details